Keybanc Maintains Overweight on Applied Materials, Raises Price Target to $750
Keybanc raises AMAT price target to $750.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Needham Maintains Buy on Praxis Precision Medicine, Raises Price Target to $575
Needham analyst Ami Fadia maintains Praxis Precision Medicine (NASDAQ: PRAX ) with a Buy and raises the price target from $537 to $575.